Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/7928
Title: | Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 | Authors: | Abenavoli L. Masarone M. Peta V. Milić, Nataša Kobyliak N. Rouabhia S. Persico M. |
Issue Date: | 1-Jan-2014 | Journal: | World Journal of Gastroenterology | Abstract: | © 2014 Baishideng Publishing Group Inc. All rights reserved. Hepatitis C virus (HCV) infection is a common chronic liver disease worldwide. Non-alcoholic fatty liver disease and insulin resistance (IR) are the major determinants of fibrosis progression and response to antiviral therapy. The pathogenetic link between IR and chronic HCV infection is complex, and is associated with HCV genotype. Liver steatosis is the most common in the patients infected with genotype 3 virus, possibly due to direct effects of genotype 3 viral proteins. To the contrary, hepatic steatosis in the patients infected with other genotypes is thought to be mostly due to the changes in host metabolism, involving IR. In HCV genotype 3, liver steatosis correlates with viral load, reverts after reaching the sustained virologic response and reoccurs in the relapsers. A therapeutic strategy to improve IR and liver steatosis and subsequently the response to antiviral treatment in these patients is warranted. | URI: | https://open.uns.ac.rs/handle/123456789/7928 | ISSN: | 10079327 | DOI: | 10.3748/wjg.v20.i41.15233 |
Appears in Collections: | MDF Publikacije/Publications |
Show full item record
SCOPUSTM
Citations
54
checked on May 10, 2024
Page view(s)
4
Last Week
1
1
Last month
0
0
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.